Cargando…
Development of RECLS score to predict survival in lung cancer patients with malignant pleural effusion
BACKGROUND: Malignant pleural effusion (MPE) is usually caused by lung cancer, and the prognostic factors are poorly understood. We aimed to develop models to predict the survival of lung cancer patients and lung adenocarcinoma patients with MPE. METHODS: We enrolled lung cancer patients with MPE in...
Autores principales: | Zhang, Tianli, Chen, Xi, Wan, Bing, Xu, Yangyang, Liu, Hongbing, Lv, Tangfeng, Zhan, Ping, Song, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044486/ https://www.ncbi.nlm.nih.gov/pubmed/33889512 http://dx.doi.org/10.21037/tlcr-20-1191 |
Ejemplares similares
-
The diagnostic yield of closed needle pleural biopsy in exudative pleural effusion: a retrospective 10-year study
por: Zhang, Tianli, et al.
Publicado: (2020) -
Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma
por: Xu, Ke, et al.
Publicado: (2023) -
Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer
por: Xu, Yangyang, et al.
Publicado: (2022) -
Efficacy and safety of recombinant human tumor necrosis factor application for the treatment of malignant pleural effusion caused by lung cancer
por: Li, Qian, et al.
Publicado: (2015) -
The role of LENT and PROMISE scores in predicting survival in malignant pleural effusion
por: Ermin, Sinem, et al.
Publicado: (2022)